Événements

Événements recommandés

ACTIF

Updates on ESC heart failure guidelines

A VENIR

Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin

ACTIF

Practicalities of SGLT2 inhibition – pros vs cons

A VENIR

Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF

A VENIR

Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF

ACTIF

Practicalities of SGLT2 inhibition – pros vs cons

A VENIR

Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin

ACTIF

COVID-19 and its implications in heart failure